Delivery Order SPE2DB22D2206-SPE2DB24FEE44
- Not listed
- This federal contract award, SPE2DB20D3103|SPE2DB23FM1E4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorothiazide Sodium 500 mg vials. The $1,030.01 fixed-price delivery order has a completion date of January 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials, with a ceiling value of $11,019.75 and a firm fixed price structure. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 15, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $13,400.56 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials, with an ultimate completion date of September 23, 2025. This competitive award, issued on September 22, 2025, utilizes a firm fixed-price contract type with no set-aside designation. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of CHLOROTHIAZIDE SOD 500 MG VIALS, a pharmaceutical product, with a ceiling value of $3,635.63 and a period of performance through July 10, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp also...
- The Defense Logistics Agency awarded a delivery order valued at $6,178.70 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials. This non-set-aside, competitively awarded contract utilizing firm fixed pricing is scheduled for completion by July 15, 2025, with performance to take place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,456.75 Firm Fixed Price Delivery Order is for the supply of 4560815825 CHLORDIAZEPOXIDE-CLIDINIUM CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of May 4, 2023. The award is not associated with any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB23FY6VF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,537.43 firm fixed-price delivery order is for the supply of 400 milliequivalents per 100 milliliters of sodium chloride, a critical medical product. The contract has an ultimate completion date of May 4, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 0.9% sodium chloride solution in 250 mL volumes. The $1,840.28 firm fixed-price contract has an ultimate completion date of August 2, 2022. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- The Defense Logistics Agency issued a $2,549.85 delivery order to Amerisourcebergen Drug Corp on May 6, 2026, for chlorothiazide sodium 500 mg vials with ultimate completion on May 7, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied. Amerisourcebergen Drug Corp operates as the execution entity for DLA pharmaceutical distribution within the Cencora, Inc. parent structure and holds a single-award indefinite delivery contract (SPE2DX) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of sodium chloride 0.9% solution 100ml. The contract, valued at $1,834.41, is a firm fixed-price delivery order without any set-aside designations. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEE44Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $7,139.62, is a delivery order for the supply of 4,562,841,156 units of Chlorothiazide Sodium 500 mg vials. The contract has an ultimate completion date of November 17, 2023, and is a firm fixed-price contract. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 11/16/23 |